Leibniz Institute DSMZ
DSMZ Digital Diversity
Login
Classic view
All enzymes
Enzyme history
BRENDA support
Any feedback?
Please rate this page
(search_result.php)
😁
😐
😡
(
0
/150)
Send feedback
BRENDA support
Refine search
Search Reference
Reference:
show
10
50
100
results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Recommended Name:
EC Number:
contains
exact
begins with
ends with
use * as joker
BRENDA No.:
contains
exact
begins with
ends with
use * as joker
Authors:
contains
exact
begins with
ends with
use * as joker
Journal:
contains
exact
begins with
ends with
use * as joker
Volume:
contains
exact
begins with
ends with
use * as joker
Pages:
contains
exact
begins with
ends with
use * as joker
Year:
=
<
>
between min-max
use * as joker
Organism:
contains
exact
begins with
ends with
use * as joker
PubMed ID:
=
<
>
between min-max
use * as joker
Show additional data
do not include text mining results
include
results
(Automatic Mining of Enzyme Data)
include
results
(AMENDA + additional results, but less precise)
Search term:
Results
21
-
29
of
29
download as CSV
download all results as CSV
EC Number
BRENDA No.
Title
Journal
Volume
Pages
Year
Organism
PubMed ID
3.4.23.47
644058
Molecular modeling of the HIV-2 protease
Adv. Exp. Med. Biol.
306
549-553
1991
Human immunodeficiency virus 2
1812757
3.4.23.47
677596
Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors
Antimicrob. Agents Chemother.
51
604-610
2007
Human immunodeficiency virus 2
17116674
3.4.23.47
644060
Regulation of autoproteolysis of the HIV-1 and HIV-2 proteases with engineered amino acid substitutions
J. Biol. Chem.
268
11939-11945
1993
Human immunodeficiency virus 2
8505318
3.4.23.47
735264
Revealing origin of decrease in potency of darunavir and amprenavir against HIV-2 relative to HIV-1 protease by molecular dynamics simulations
Sci. Rep.
4
6872
2014
HIV-2 subtype A
25362963
3.4.23.47
710496
Revealing the dimer dissociation and existence of a folded monomer of the mature HIV-2 protease
Protein Sci.
18
2442-2453
2009
Human immunodeficiency virus 2
19798742
3.4.23.47
644069
Reversible oxidation of HIV-2 protease
Methods Enzymol.
348
249-259
2002
Human immunodeficiency virus 2
11885278
3.4.23.47
644057
Synthetic HIV-2 protease cleaves the GAG precursor of HIV-1 with the same specificity as HIV-1 protease
Arch. Biochem. Biophys.
277
306-311
1990
Human immunodeficiency virus 2
2178555
3.4.23.47
644064
The differential processing of homodimers of reverse transcriptases from human immunodeficiency viruses type 1 and 2 is a consequence of the distinct specificities of the viral proteases
J. Biol. Chem.
270
13573-13579
1995
Human immunodeficiency virus 2
7539431
3.4.23.47
678937
Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database
BMC Infect. Dis.
8
21
2008
Human immunodeficiency virus 2
18304321
Results
21
-
29
of
29
download as CSV
download all results as CSV